Thermo Fisher Scientific has launched the Oncomine Childhood Cancer Research Assay, a next-generation sequencing panel developed in collaboration with Children’s Hospital Los Angeles.
To fully benefit from the vast quantities of data from TCGA, tools for easy data visualisation and analysis must be developed for use of the non-computational scientist. Our panel of experts discuss TCGA data and the tools needed to make sense of it.
The companies plan to develop a diagnostic version of the Illumina TruSight Oncology 500 assay to measure potentially predictive biomarkers, including Tumour Mutation Burden (TMB).
The FDA said yesterday it will relax its review of some genetic tests that examine millions of different variants at the same time, and finalised two guidances designed to enhance collaboration among researchers, and drive the efficient development of novel NGS-based tests.
Illumina and Loxo Oncology have announced a global strategic partnership to develop a diagnostic tool that will work with Loxo’s larotrectinib and another of its experimental cancers drugs, across tumour types.
Learn more about Edico Genome’s new DRAGEN Virtual Long-Read Detection (VLRD) Pipeline, that’s the first variant caller dedicated to SDs, and is designed to run with short sequence reads generated at moderate coverage.
DNAnexus launches new clinical trial solution that aims to streamline the incorporation of human genomic data into clinical trial designs.
Stephen Kingsmore and his team at Rady Children’s recently proved they could sequence a whole genome in a world record time of 19.5 hours.
Do you have an idea rolling around in your head with no resources to test it? Why not apply for Archer Research Challenge Grants? 2018 might be your time to shine.
Festival of Genomics London 2018: GenomeAsia 100k is addressing the lack of genomic data from South Asians by launching the “Map the Gap” campaign.